GCTK
GlucoTrack, Inc.
Price Chart
Latest Quote
$0.36
+0.00 (+0.14%)
Current Price
| Previous Close | $0.36 |
| Open | $0.36 |
| Day High | $0.37 |
| Day Low | $0.35 |
| Volume | 215,839 |
Stock Information
| Shares Outstanding | 6.26M |
| Total Debt | $3.59M |
| Cash Equivalents | $3.93M |
| Net Income | $-16.89M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $2.28M |
| P/E Ratio | 0.06 |
| EPS (TTM) | $6.27 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.94M |
| Income | $-16.89M |
| Book/sh | $-0.34 |
| Cash/sh | $0.63 |
| Employees | 15 |
Financial Ratios
| Quick Ratio | 0.79 |
| Current Ratio | 0.85 |
Returns & Margins
| ROA | -150.30% |
| ROE | -527.21% |
Ownership
| Insider Ownership | 0.94% |
| Institutional Ownership | 4.34% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | -1.08 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.52 |
| SMA50 | $0.64 |
| SMA200 | $3.30 |
| RSI | 9.19 |
| ATR | 0.0687 |
| Shares Float | 6.16M |
| Short Float | 5.82% |
| Short Ratio | 0.04 |
| Volatility | 0.69 |
| Rel Volume | 0.21 |
Performance History
| Week | -10.25% |
| Month | -21.13% |
| Quarter | -65.94% |
| 6 Months | -92.21% |
| YTD | -90.61% |
| Year | -94.23% |
| 3 Years | -99.99% |
| 5 Years | -100.00% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $0.36 | 215,839 |
| 2026-06-22 | $0.36 | 138,600 |
| 2026-06-18 | $0.37 | 293,800 |
| 2026-06-17 | $0.38 | 173,300 |
| 2026-06-16 | $0.40 | 704,000 |
| 2026-06-15 | $0.41 | 1,788,900 |
| 2026-06-12 | $0.39 | 541,800 |
| 2026-06-11 | $0.41 | 9,576,100 |
| 2026-06-10 | $0.40 | 1,097,000 |
| 2026-06-09 | $0.50 | 235,500 |
| 2026-06-08 | $0.54 | 383,700 |
| 2026-06-05 | $0.61 | 388,000 |
| 2026-06-04 | $0.67 | 339,800 |
| 2026-06-03 | $0.67 | 547,300 |
| 2026-06-02 | $0.66 | 356,300 |
| 2026-06-01 | $0.66 | 376,800 |
| 2026-05-29 | $0.66 | 405,400 |
| 2026-05-28 | $0.65 | 315,100 |
| 2026-05-27 | $0.64 | 1,599,100 |
| 2026-05-26 | $0.60 | 986,000 |
About GlucoTrack, Inc.
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
đ° Latest News
Glucotrack Submits Blood Glucose Monitoring Technology to FDA
Exec Edge âĸ 2026-05-07T19:50:42Z
Glucotrack Shows Long-Term Accuracy of Implantable Glucose Monitor
Exec Edge âĸ 2026-04-30T20:56:52Z
Study Supports GlucoTrackâs Blood Glucose Monitoring Implant
Exec Edge âĸ 2026-04-21T15:59:46Z
Glucotrack to File for FDA Exemption Based on 2025 Milestones
Exec Edge âĸ 2026-03-28T01:59:54Z
BC-Most Active Stocks
Associated Press Finance âĸ 2026-03-27T14:30:19ZGlucotrack Announces 3 New Patents to Monitor Blood Glucose
Exec Edge âĸ 2026-01-29T22:42:48Z
Wall Street Set to Open Little Changed Friday Ahead of Consumer Sentiment Report
MT Newswires âĸ 2025-09-12T13:21:29ZExchange-Traded Funds Higher, Equity Futures Mixed Ahead of September Consumer Sentiment Report
MT Newswires âĸ 2025-09-12T13:12:18ZConsumer Sentiment, Oil Inventory Reports Set for Release as US Futures Little Changed in Friday's Premarket Session
MT Newswires âĸ 2025-09-12T12:03:49ZSector Update: Health Care Stocks Advance Late Afternoon
MT Newswires âĸ 2025-06-25T20:04:59Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $16,090,000 | $14,547,000 | $7,104,000 | $4,432,000 |
| Other Income Expense | $-3,241,000 | $-7,467,000 | $-10,000 | $-14,000 |
| Other Non Operating Income Expenses | $26,000 | $-1,911,000 | - | $-14,000 |
| Net Non Operating Interest Income Expense | $-57,000 | $-583,000 | $17,000 | $11,000 |
| Total Other Finance Cost | $57,000 | $583,000 | - | - |
| Operating Expense | $16,090,000 | $14,547,000 | $7,104,000 | $4,432,000 |
| General And Administrative Expense | $6,277,000 | $5,048,000 | $2,275,000 | $2,454,000 |
| Interest Expense | - | $628,000 | $0 | - |
| Interest Expense Non Operating | - | $628,000 | $0 | - |
| Selling And Marketing Expense | - | $393,000 | $122,000 | $0 |
| Other Operating Expenses | - | - | - | $8,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-19,388,000 | $-22,597,000 | $-7,097,000 | $-4,435,000 |
| Net Interest Income | $-57,000 | $-583,000 | $17,000 | $11,000 |
| Normalized Income | $-16,121,000 | $-17,041,000 | $-7,087,000 | $-4,435,000 |
| Net Income From Continuing And Discontinued Operation | $-19,388,000 | $-22,597,000 | $-7,097,000 | $-4,435,000 |
| Net Income Common Stockholders | $-19,388,000 | $-22,597,000 | $-7,952,000 | $-4,435,000 |
| Net Income | $-19,388,000 | $-22,597,000 | $-7,097,000 | $-4,435,000 |
| Net Income Including Noncontrolling Interests | $-19,388,000 | $-22,597,000 | $-7,097,000 | $-4,435,000 |
| Net Income Continuous Operations | $-19,388,000 | $-22,597,000 | $-7,097,000 | $-4,435,000 |
| Pretax Income | $-19,388,000 | $-22,597,000 | $-7,097,000 | $-4,435,000 |
| Special Income Charges | $0 | $-4,758,000 | $0 | $0 |
| Operating Income | $-16,090,000 | $-14,547,000 | $-7,104,000 | $-4,432,000 |
| Interest Income | - | $62,000 | $17,000 | $11,000 |
| Total Operating Income As Reported | - | $-14,547,000 | $-7,104,000 | $-4,432,000 |
| Interest Income Non Operating | - | $62,000 | $17,000 | $11,000 |
| Depreciation Amortization Depletion Income Statement | - | $22,000 | $3,000 | $3,000 |
| Depreciation And Amortization In Income Statement | - | $22,000 | $3,000 | $3,000 |
| Depreciation Income Statement | - | $22,000 | $3,000 | $3,000 |
| Per Share | ||||
| Diluted EPS | $-31.22 | $-4106.00 | $-2050.80 | $-1740.00 |
| Basic EPS | $-31.22 | $-4106.00 | $-2050.80 | $-1740.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-12,781,000 | $-8,955,000 | $-7,074,000 | $-4,409,000 |
| Total Unusual Items | $-3,267,000 | $-5,556,000 | $-10,000 | $0 |
| Total Unusual Items Excluding Goodwill | $-3,267,000 | $-5,556,000 | $-10,000 | $0 |
| Reconciled Depreciation | $42,000 | $36,000 | $13,000 | $23,000 |
| EBITDA (Bullshit earnings) | $-16,048,000 | $-14,511,000 | $-7,084,000 | $-4,409,000 |
| EBIT | $-16,090,000 | $-14,547,000 | $-7,097,000 | $-4,432,000 |
| Diluted Average Shares | $621,094 | $5,503 | $3,460 | $2,579 |
| Basic Average Shares | $621,094 | $5,503 | $3,460 | $2,579 |
| Diluted NI Availto Com Stockholders | $-19,388,000 | $-22,597,000 | $-7,952,000 | $-4,435,000 |
| Gain On Sale Of Security | $-3,267,000 | $-798,000 | $-10,000 | - |
| Research And Development | $9,813,000 | $9,499,000 | $4,704,000 | $1,967,000 |
| Selling General And Administration | $6,277,000 | $5,048,000 | $2,397,000 | $2,454,000 |
| Other Gand A | $6,277,000 | $5,048,000 | $1,599,000 | $1,380,000 |
| Otherunder Preferred Stock Dividend | - | $0 | $855,000 | $0 |
| Other Special Charges | - | $4,758,000 | - | - |
| Insurance And Claims | - | $313,000 | $336,000 | $457,000 |
| Salaries And Wages | - | $476,000 | $340,000 | $617,000 |
| Write Off | - | - | - | $0 |
Fetched: 2026-06-21
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $2,828,000 | $-13,000,000 | $3,197,000 | $1,230,000 |
| Total Assets | $7,838,000 | $5,932,000 | $4,905,000 | $2,438,000 |
| Total Non Current Assets | $171,000 | $164,000 | $37,000 | $59,000 |
| Current Assets | $7,667,000 | $5,768,000 | $4,868,000 | $2,379,000 |
| Other Current Assets | $284,000 | $151,000 | $376,000 | $67,000 |
| Cash Cash Equivalents And Short Term Investments | $7,383,000 | $5,617,000 | $4,492,000 | $2,312,000 |
| Cash And Cash Equivalents | $7,383,000 | $5,617,000 | $4,492,000 | $2,312,000 |
| Other Non Current Assets | - | $10,000 | $10,000 | $19,000 |
| Inventory | - | - | - | - |
| Receivables | - | - | - | - |
| Accounts Receivable | - | - | - | - |
| Debt | ||||
| Total Debt | $3,446,000 | $267,000 | $196,000 | $195,000 |
| Long Term Debt And Capital Lease Obligation | $236,000 | $236,000 | $196,000 | $195,000 |
| Long Term Debt | $231,000 | $203,000 | $196,000 | $195,000 |
| Current Debt And Capital Lease Obligation | $3,210,000 | $31,000 | - | - |
| Current Debt | $3,182,000 | $5,000 | - | - |
| Other Current Borrowings | - | $5,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $5,010,000 | $18,932,000 | $1,708,000 | $1,208,000 |
| Total Non Current Liabilities Net Minority Interest | $237,000 | $17,657,000 | $196,000 | $195,000 |
| Derivative Product Liabilities | $1,000 | $17,421,000 | $0 | - |
| Current Liabilities | $4,773,000 | $1,275,000 | $1,512,000 | $1,013,000 |
| Other Current Liabilities | $246,000 | $252,000 | $673,000 | $341,000 |
| Current Notes Payable | $3,182,000 | $0 | - | - |
| Payables And Accrued Expenses | $1,317,000 | $992,000 | $839,000 | $672,000 |
| Payables | $1,317,000 | $992,000 | $839,000 | $672,000 |
| Accounts Payable | $1,317,000 | $992,000 | $839,000 | $672,000 |
| Equity | ||||
| Common Stock Equity | $2,828,000 | $-13,000,000 | $3,197,000 | $1,230,000 |
| Total Equity Gross Minority Interest | $2,828,000 | $-13,000,000 | $3,197,000 | $1,230,000 |
| Stockholders Equity | $2,828,000 | $-13,000,000 | $3,197,000 | $1,230,000 |
| Other Equity Interest | $3,544,000 | $228,000 | $48,000 | $4,000 |
| Gains Losses Not Affecting Retained Earnings | $41,000 | $-8,000 | $16,000 | $17,000 |
| Other Equity Adjustments | $41,000 | $-8,000 | $16,000 | $17,000 |
| Retained Earnings | $-151,838,000 | $-132,450,000 | $-109,853,000 | $-101,901,000 |
| Other | ||||
| Ordinary Shares Number | $910,688 | $13,193 | $3,482 | $2,583 |
| Share Issued | $910,688 | $13,193 | $3,482 | $2,583 |
| Tangible Book Value | $2,828,000 | $-13,000,000 | $3,197,000 | $1,230,000 |
| Invested Capital | $6,241,000 | $-12,792,000 | $3,393,000 | $1,425,000 |
| Working Capital | $2,894,000 | $4,493,000 | $3,356,000 | $1,366,000 |
| Capital Lease Obligations | $33,000 | $59,000 | $0 | $0 |
| Total Capitalization | $3,059,000 | $-12,797,000 | $3,393,000 | $1,425,000 |
| Additional Paid In Capital | $151,080,000 | $119,229,000 | $112,986,000 | $103,095,000 |
| Capital Stock | $1,000 | $1,000 | $0 | $15,000 |
| Common Stock | $1,000 | $1,000 | $0 | $15,000 |
| Long Term Capital Lease Obligation | $5,000 | $33,000 | $0 | $0 |
| Current Capital Lease Obligation | $28,000 | $26,000 | $0 | $0 |
| Net PPE | $171,000 | $154,000 | $27,000 | $40,000 |
| Gross PPE | $171,000 | $154,000 | $27,000 | $40,000 |
| Other Properties | $171,000 | $154,000 | $27,000 | $40,000 |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | - | $16,000 |
| Current Accrued Expenses | - | - | - | $325,000 |
| Accumulated Depreciation | - | - | - | $-254,000 |
| Machinery Furniture Equipment | - | - | - | $294,000 |
| Leases | - | - | - | - |
| Properties | - | - | - | - |
| Inventories Adjustments Allowances | - | - | - | - |
| Finished Goods | - | - | - | - |
| Work In Process | - | - | - | - |
| Raw Materials | - | - | - | - |
Fetched: 2026-06-21
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-15,336,000 | $-12,594,000 | $-6,558,000 | $-3,730,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-15,240,000 | $-12,490,000 | $-6,558,000 | $-3,729,000 |
| Cash Flow From Continuing Operating Activities | $-15,240,000 | $-12,490,000 | $-6,558,000 | $-3,729,000 |
| Operating Gains Losses | $3,283,000 | $798,000 | - | $1,000 |
| Investing Activities | ||||
| Capital Expenditure | $-96,000 | $-104,000 | - | $-1,000 |
| Investing Cash Flow | $-96,000 | $-104,000 | $0 | $1,000 |
| Cash Flow From Continuing Investing Activities | $-96,000 | $-104,000 | $0 | $1,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $14,209,000 | $9,283,000 | $8,730,000 | $0 |
| Financing Cash Flow | $17,043,000 | $13,743,000 | $8,730,000 | $0 |
| Cash Flow From Continuing Financing Activities | $17,043,000 | $13,743,000 | $8,730,000 | $0 |
| Net Common Stock Issuance | $14,209,000 | $9,283,000 | $8,730,000 | $0 |
| Common Stock Issuance | $14,209,000 | $9,283,000 | $8,730,000 | $0 |
| Other | ||||
| Issuance Of Debt | $3,000,000 | $4,460,000 | $0 | - |
| End Cash Position | $7,383,000 | $5,627,000 | $4,502,000 | $2,331,000 |
| Beginning Cash Position | $5,627,000 | $4,502,000 | $2,331,000 | $6,113,000 |
| Effect Of Exchange Rate Changes | $49,000 | $-24,000 | $-1,000 | $-54,000 |
| Changes In Cash | $1,707,000 | $1,149,000 | $2,172,000 | $-3,728,000 |
| Proceeds From Stock Option Exercised | $-166,000 | $0 | - | - |
| Net Issuance Payments Of Debt | $3,000,000 | $4,460,000 | $0 | - |
| Net Short Term Debt Issuance | $3,000,000 | $4,460,000 | $0 | - |
| Short Term Debt Issuance | $3,000,000 | $4,460,000 | $0 | - |
| Net PPE Purchase And Sale | $-96,000 | $-104,000 | $0 | $1,000 |
| Purchase Of PPE | $-96,000 | $-104,000 | $0 | $-1,000 |
| Change In Working Capital | $209,000 | $67,000 | $190,000 | $184,000 |
| Change In Other Current Liabilities | $17,000 | $-421,000 | $332,000 | $138,000 |
| Change In Other Current Assets | $-133,000 | $225,000 | $-309,000 | $-28,000 |
| Change In Payables And Accrued Expense | $325,000 | $263,000 | $167,000 | $74,000 |
| Change In Payable | $325,000 | $263,000 | $167,000 | $74,000 |
| Change In Account Payable | $325,000 | $263,000 | $167,000 | $74,000 |
| Other Non Cash Items | $403,000 | $9,033,000 | $55,000 | $59,000 |
| Stock Based Compensation | $211,000 | $173,000 | $281,000 | $439,000 |
| Depreciation Amortization Depletion | $42,000 | $36,000 | $13,000 | $23,000 |
| Depreciation And Amortization | $42,000 | $36,000 | $13,000 | $23,000 |
| Depreciation | $42,000 | $36,000 | $13,000 | $23,000 |
| Gain Loss On Investment Securities | $3,267,000 | $798,000 | - | - |
| Gain Loss On Sale Of PPE | $16,000 | $0 | $0 | $1,000 |
| Net Income From Continuing Operations | $-19,388,000 | $-22,597,000 | $-7,097,000 | $-4,435,000 |
| Interest Paid Supplemental Data | - | - | $0 | - |
| Sale Of PPE | - | - | $0 | $2,000 |
| Change In Inventory | - | - | - | $0 |
| Change In Receivables | - | - | - | $0 |
| Changes In Account Receivables | - | - | - | $0 |
Fetched: 2026-06-21